Muscle mass, strength, bone mineral density and vascular function in middle-aged people living with HIV vs.

Karynne Grutter Lopes1, Paulo Farinatti2, Gabriella de Oliveira Lopes3

  • 1Laboratory of Physical Activity and Health Promotion, Institute of Physical Education and Sports, University of Rio de Janeiro State, Rio de Janeiro, RJ, Brazil; Laboratory for Clinical and Experimental Research on Vascular Biology, University of Rio de Janeiro State, Rio de Janeiro, RJ, Brazil; Graduate Program in Clinical and Experimental Physiopathology, University of Rio de Janeiro State, Rio de Janeiro, Brazil.

Insights

Middle-aged individuals with HIV on combination antiretroviral therapy (cART) show similar muscle mass and strength to controls, but may experience accelerated bone density loss, approaching levels seen in older adults.

Area of Science:

  • Gerontology
  • Infectious Diseases
  • Orthopedics
  • Cardiology

Background:

  • Combination antiretroviral therapy (cART) has improved longevity for people living with HIV (PLHIV).
  • Prolonged HIV infection and cART are associated with increased risk of comorbidities, potentially accelerating age-related disorders.
  • This study investigates the impact of long-term cART on muscle, bone, and vascular health in middle-aged PLHIV.

Purpose of the Study:

  • To compare muscle mass, strength, bone mineral density (BMD), and vascular function in middle-aged PLHIV on cART versus age-matched and older controls.
  • To assess potential acceleration of age-related comorbidities in PLHIV due to prolonged HIV infection and treatment.

Main Methods:

  • Cross-sectional study involving 12 PLHIV on cART, 12 age-matched controls, and 12 older controls.
  • Assessments included dual-energy X-ray absorptiometry for body composition and BMD, isokinetic dynamometry for muscle strength, and venous occlusion plethysmography for vascular function.
  • Participants were carefully screened for secondary conditions and medications.

Main Results:

  • Relative muscle mass and isokinetic strength were similar between PLHIV and age-matched controls, but significantly greater than in older controls.
  • Total BMD was similar in PLHIV and older controls, and both groups had lower BMD than age-matched controls.
  • No significant differences in macrovascular reactivity were observed across the three groups.

Conclusions:

  • Middle-aged PLHIV on prolonged cART may experience accelerated age-related osteopenia, with BMD values comparable to older adults.
  • Muscle mass, isokinetic strength, and vasodilation capacity remain preserved in PLHIV compared to age-matched uninfected individuals.
  • Findings suggest a need for monitoring bone health in PLHIV undergoing long-term cART.
Abstract

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
4.2K
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
2.9K
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
18
Changes in the Appendicular Skeleton with Age01:09

Changes in the Appendicular Skeleton with Age

The upper and lower limb initially develops as a small bulge called a limb bud, which appears on the lateral side of the early embryo. The upper limb bud appears near the end of the fourth week of development, with the lower limb bud appearing shortly after.
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
2.8K
Exercise and Muscle Performance01:27

Exercise and Muscle Performance

Exercise induces a range of adaptations in muscle tissue, depending on the type and duration of activity. Such physical training can be broadly categorized into two types: endurance exercises and resistance exercises.
Endurance exercises
Endurance exercises involve running, swimming, or cycling, which require repetitive movements with low force output. When a person engages in endurance exercise, a few noticeable changes occur in their skeletal muscles. For instance, the number of capillaries...
1.8K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
23